Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma

---

YÜKSEL N., Gok M., Altintas O., Caglar Y.

CURRENT EYE RESEARCH, vol.36, no.9, pp.804-808, 2011 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 36 Issue: 9
• Publication Date: 2011
• Doi Number: 10.3109/02713683.2011.584651
• Journal Name: CURRENT EYE RESEARCH
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.804-808
• Kocaeli University Affiliated: Yes

Abstract

Purpose: To evaluate the 6-month daytime efficacy of a fixed combination of timolol and brimonidine (BTFC) versus a timolol and dorzolamide fixed combination (DTFC) as a first choice therapy in patients with pseudoexfoliation glaucoma (PXG).